Aminotetralin derivatives as muscarinic receptor antagonists

Details for Australian Patent Application No. 2002352124 (hide)

Owner F. HOFFMANN-LA ROCHE AG

Inventors Weikert, Robert James; Madera, Ann Marie

Agent Spruson & Ferguson

Pub. Number AU-A-2002352124

PCT Number PCT/EP02/13219

PCT Pub. Number WO2003/048125

Priority 60/336,675 03.12.01 US

Filing date 25 November 2002

Wipo publication date 17 June 2003

International Classifications

C07D 211/58 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 013/10 Drugs for disorders of the urinary system

C07D 211/60 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

C07D 401/10 Heterocyclic compounds containing two or more hetero rings

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/336,675 03.12.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002352124

18 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352125-4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists

2002352123-N-ureido-piperidines as antagonists VIII for CCR-3 receptor